Printer Friendly
The Free Library
14,380,430 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Browse Biopharmaceuticals topic

Subtopics (48)

 

Articles

1-100 out of 100 article(s)
Title Author Type Date Words
BioInvent Signs Licensing Agreement with Daiichi Sankyo for the Discovery and Development of Therapeutic Antibodies. Nov 13, 2009 510
PIKAMAB to Customize Cancer Antibody Therapies. Nov 12, 2009 839
United States : Bristol-Myers Inks Development Deal With Alder. Nov 11, 2009 172
United States : Alder Biopharmaceuticals and Bristol-Myers Squibb sign deal worth up to $1B. Nov 11, 2009 189
United States : Sanofi Expands Regeneron Deal. Nov 11, 2009 352
MONEY BRIEFS. Nov 11, 2009 633
Bristol-Myers Squibb and Alder Biopharmaceuticals Enter Global Agreement on Rheumatoid Arthritis Biologic. Nov 10, 2009 1003
D-Pharm Enters Into Collaboration With Wanbang Biopharmaceuticals. Clinical report Nov 9, 2009 421
United States : Micromet and Sanofi-aventis Sign Global Collaboration and License Agreement for New Solid Tumor BiTE Antibody. Nov 2, 2009 185
Major advance in human antibody therapy against deadly Nipah virus. Nov 1, 2009 358
United States : Inventive Approach May Improve Enzyme Replacement Therapy For Fabry Disease. Oct 26, 2009 467
Germany : Lonza Acquires Stake in Cilian AG. Oct 23, 2009 230
KYTHERA Biopharmaceuticals Announces Two Data Presentations on Its Novel Fat Reduction Drug at ASPS Meeting. Oct 22, 2009 161
New England Journal of Medicine Article: Biogenerics Legislation Should Grant 5 Years Exclusivity. Oct 15, 2009 415
Enzo Biochem's Life Sciences Subsidiary Unveils Comprehensive Menu of Epigenetics Tools at Society for Neurosciences Meeting. Conference news Oct 15, 2009 719
Company Profile for KYTHERA Biopharmaceuticals, Inc. Company overview Oct 9, 2009 95
Korea : Hospira and Celltrion agree to develop and market eight biogeneric products. Oct 9, 2009 233
United States : KYTHERA Biopharmaceuticals presents its two Phase 2 clinical study results. Clinical report Oct 3, 2009 259
KYTHERA Biopharmaceuticals Presents Positive Data From Two Phase 2 Studies With ATX-101. Clinical report Oct 2, 2009 744
KYTHERA Biopharmaceuticals Announces Presentation of Phase 2 Data on Novel Fat Reduction Drug at ASDS Meeting. Oct 1, 2009 158
Xcellerex and Itero Biopharmaceuticals Announce Strategic Manufacturing and Supply Collaboration. Oct 1, 2009 642
KYTHERA Biopharmaceuticals Announces Presentation of Phase 2 Data on Novel Fat Reduction Drug at ASDS Meeting. Sep 30, 2009 158
RegeneRx Biopharmaceuticals to Present Several Papers at Second International Symposium on Thymosins in Health and Disease. Sep 24, 2009 863
Pancreatic and Colorectal Cancer Novel Antibody Developed from a Vaccine to Begin Phase I Trial. Sep 17, 2009 423
KYTHERA Biopharmaceuticals Announces Initiation of First-in-Human Trial for ATX-104 - A Light-Activated Facial Contouring Agent. Sep 15, 2009 285
PicksThatMove.com Announces Investment Opinion: Small Cap Biopharmaceuticals and Biotechnology 101 from PicksThatMove. Sep 15, 2009 503
Roche xCELLigence System for Cell Analysis to Provide Predictive Mechanistic Information for Small Molecule Compounds. Aug 26, 2009 654
(SCI) TURKISH RESEARCHERS SUCCEED IN PRODUCING THERAPEUTIC PROTEIN FROM TRANSGENIC RATS. Aug 26, 2009 248
Morria Biopharmaceuticals Plc. Obtains Institutional Review Board Clearance to Conduct Phase II Study in Contact Dermatitis Patients Using MRX6, a Novel Topical Anti-Inflammatory Drug. Aug 25, 2009 334
Omnia Biologics and AparnaBio Sign Lentivirus Drug Development Agreement. Aug 18, 2009 232
Debiopharm and MSM Protein Technologies Sign Agreement for Research and Development of Debio 0929, a Novel Oncology Biologic. Jul 30, 2009 719
Research and Markets: Quality by Design for Biopharmaceuticals: Principles and Case Studies - The Concepts, Applications, and Practical Issues of Quality by Design. Jul 27, 2009 471
Nature Reviews: Drug Discovery Article Describes Design of Glycomimetic Compounds and Newly "Druggable" Disease Targets. Jul 24, 2009 587
PCMA Vows Continued Support for Real Biogenerics Reform Despite Committee Vote. Jul 14, 2009 239
Medarex and Lonza Sign Collaboration Agreement for the Supply of Antibody-Based Products. Jul 9, 2009 816
New PCMA Ad on Biogenerics: 'Bio-Illogic'. Jul 9, 2009 315
PCMA on Biogenerics Legislation: A Bellwether for Broader Health Reform Prospects. Jul 6, 2009 294
India: Caliper Life Sciences Introduces Staccato Protein Workstation for Automated Protein Sample Preparation & Analysis. Jul 1, 2009 344
Leerink Swann's Partnering & Acquisitions for Commercial Stage Biopharmaceuticals Investment Analysis Now Available. Jun 30, 2009 385
United States: RegeneRx Biopharmaceuticals announces collaboration with USAMRICD. Jun 26, 2009 127
Newcastle University centre acts as catalyst for bioprocessing collaboration. Jun 25, 2009 548
RegeneRx Working with U.S. Military to Test T4 Against Exposure to Chemical Agents in the Eye. Jun 22, 2009 767
PCMA: President Obama, MedPAC Call for Follow-On Biologics. Jun 15, 2009 410
BioSeek and Merck Serono Extend 2008 Agreement. Jun 10, 2009 356
Alder Biopharmaceuticals Announces Expanded Collaboration With Schering-Plough. Jun 8, 2009 355
Alder Biopharmaceuticals Presents Results From Phase 1 Trial of ALD518 in Advanced Cancer at American Society of Clinical Oncology Annual Meeting. Jun 1, 2009 486
PCMA on New GAO Report: Shows Urgent Need for Biogenerics Legislation. Jun 1, 2009 253
GMP violations cited at Qingdao Jiulong Biopharmaceuticals. Mashaw, Rebecca May 1, 2009 1079
AVEO Presents Novel HGF Model and Promising Preclinical Activity to Support Lead Antibody Agent SCH 900105 (AV-299). Apr 19, 2009 957
Enzyme therapy may slow deterioration of kidney function. Clinical report Apr 9, 2009 207
Aphios Granted Japanese Patent for Inactivating Viruses and Other Pathogens in Biologics and Human Plasma. Apr 7, 2009 498
PCMA Launches New Ad Campaign:'Waiting Isn't An Option' for Biogenerics. Apr 2, 2009 290
R&D SPENDING BY U.S.BIOPHARMACEUTICALS AT RECORD LEVELS IN 2008. Apr 1, 2009 841
PCMA: Bipartisan Biogenerics Legislation Will Increase Competition, Lower Costs. Mar 26, 2009 183
KYTHERA Biopharmaceuticals, Inc. Selected to Present at InsideVenture's Debut Investor Conference. Conference news Mar 24, 2009 605
Xcellerex, Collaborators Receive $11 Million Phase 2 U.S. Contract to Develop Technology for Accelerated Monoclonal Antibody and Vaccine Manufacturing. Mar 24, 2009 1034
Company Profile for Bay City Capital LLC. Mar 13, 2009 130
Defense Advanced Research Projects Agency Awards $12 Million to Fraunhofer CMB and iBioPharma for Accelerated Manufacture of Biopharmaceuticals. Mar 11, 2009 748
PCMA: New Bipartisan Biogenerics Legislation the 'Right Approach' to Increase Competition, Lower Costs. Mar 11, 2009 217
Diverse Group of Employers, Health Plans, Chain Drug Stores, Pharmacy Benefit Managers and Manufacturers Join Consumer and Labor Groups in Endorsement of Bipartisan Biogenerics Legislation. Mar 11, 2009 1088
PCMA on New AARP Study: Biogenerics Will Help Lower Specialty Drug Costs for Consumers. Mar 9, 2009 210
PCMA on Biogenerics: Important Step Forward in Health Reform. Feb 26, 2009 193
CCPM Lauds President Obama for Supporting Reasonable Exclusivity in Recommendations on Biogeneric Pathway. Feb 26, 2009 302
CCPM Applauds Waxman Biogeneric Remarks on Anniversary of Hatch-Waxman. Feb 24, 2009 370
Research and Markets: Analytical Tool - Cancer Therapeutic Antibodies. Feb 23, 2009 319
Xencor and CSL Limited Establish Antibody Optimization Collaboration. Feb 23, 2009 449
Research and Markets: Antibodies in Oncology: Exciting Drug Pipeline Update 2009. Feb 18, 2009 371
Flamel Technologies Announces Merck Serono's Exercise of Option to License Medusa Technology for Development of an Extended-Release Formulation of a Therapeutic Protein. Feb 17, 2009 626
Progenics Selects Subcutaneous Form of PRO 140, a Novel HIV Antibody Therapy, for Further Development. Feb 10, 2009 1867
INTERCELL OUTLICENSES GROUP B STREPTOCOCCUS VACCINE. Feb 1, 2009 1243
Research and Markets: Report 'Chinese Markets For Biopharmaceuticals' Provides Historical Data (1998, 2003 And 2008) and Long-Term Forecasts Through To 2013 and 2018. Jan 30, 2009 182
India : Intas Biopharmaceuticals to set up facility in Guajarat. Jan 19, 2009 104
United States : Bristol-Myers and ZymoGenetics partner in hepatitis drug development. Jan 15, 2009 301
Morphotek[R], Inc. Announces Evaluation Agreement with The University Hospital Heidelberg. Jan 14, 2009 696
AnaptysBio Adds Three to Senior Management Team to Support Growing Pipeline of Therapeutic Antibody Programs. Jan 12, 2009 791
KYTHERA Biopharmaceuticals Announces Positive Results from Two Phase 2 Studies with ATX-101 Demonstrating Reduction of Submental Fat. Clinical report Jan 6, 2009 489
Morphotek[R], Inc. Announces Research Agreement with The University of Pennsylvania to Develop Oncology Therapeutic Antibody Candidates. Dec 22, 2008 632
AliX and SOSHO to Sign Agreement for Protein Structure Determination of Intractable Targets. Dec 9, 2008 283
United States: Morphotek[R], Inc. Receives Additional $1.6M in Funding from The U.S. Department of Defense to Develop Therapeutic Antibodies Against Microbial Bioweapons. Nov 21, 2008 239
Morphotek[R], Inc. Receives Additional $1.6M in Funding from The U.S. Department of Defense to Develop Therapeutic Antibodies Against Microbial Bioweapons. Nov 20, 2008 566
Economist Finds Flaws in 14-Year Data Exclusivity Claim for Biogenerics. Nov 18, 2008 739
Compugen Chairman Presents Company Overview and Plans for 2009 at Rodman & Renshaw Healthcare Conference. Conference news Nov 12, 2008 1562
Accentia Biopharmaceuticals Announces Reorganization Plan to Maximize Long-Term Shareholder Value, Fully Pay All Creditors and Continue Operations to Commercialize Its Drug Portfolio. Nov 10, 2008 1185
Omrix Biopharmaceuticals to Webcast Presentation at Credit Suisse Annual Healthcare Conference. Conference news Nov 6, 2008 402
Omrix Biopharmaceuticals to Webcast Presentation at Rodman & Renshaw Annual Healthcare Conference. Conference news Nov 4, 2008 391
Zacks Releases New Stock Picks from +21.7% Momentum Strategy: Omrix Biopharmaceuticals, Spartan Motors, Indiana Community Bancorp, Interactive Brokers Group and DXP Enterprises. Oct 30, 2008 954
Omrix Biopharmaceuticals Announces Patient Enrollment Will Resume In Fibrin Pad U.S. Phase II Clinical Trial In Mild to Moderate Bleeding. Oct 24, 2008 450
Accentia Biopharmaceuticals to Present at Rodman & Renshaw 10th Annual Healthcare Conference; Company Also Reports On NASDAQ Compliance Plan. Oct 24, 2008 946
Viral Safety for Biopharmaceuticals: Sartorius Stedim Biotech and Bayer Technology Services Form an Alliance. Oct 20, 2008 1095
Leading Clinical Investigators and Physicians to Address Key Issues for Clinical-Stage Biopharmaceuticals at Seventh Annual BIO Investor Forum. Oct 16, 2008 1358
Omrix Biopharmaceuticals Receives Approval from European Medicines Agency for Evicel Liquid Fibrin Sealant (Human). Oct 14, 2008 498
DellaCamera Sends Letter to Nabi Biopharmaceuticals Board of Directors. Oct 10, 2008 732
Omrix Biopharmaceuticals Provides Update On Fibrin Pad U.S. Phase II Clinical Trial In Mild to Moderate Bleeding. Oct 9, 2008 386
Omrix Biopharmaceuticals Announces Interim Analysis Indicating Superiority of Fibrin Pad Versus SURGICEL in Mild to Moderate Bleeding In U.S. Phase II Clinical Trial And Provides Update On Additional Fibrin Pad Clinical Trials. Oct 8, 2008 855
Delivering Therapeutic Proteins - An Analysis of the Special Formulations and Delivery Strategies Required for Complex Therapeutic Substances. Oct 3, 2008 561
Merck Serono and Ablynx Enter Into an Agreement to Co-Discover and Co-Develop Nanobodies. Sep 1, 2008 842
Panacea Pharmaceuticals Announces Issuance of a United States Patent Covering Anti-HAAH Antibodies. Sep 1, 2008 844
Huge potential savings from biogenerics: a report by economist Dr Robert J. Shapiro, former Under Secretary of Commerce in the Clinton Administration, and commissioned by Insmed (Nasdaq: INSM), identifies potential cost savings of approximately $378 billion over the next 20 years from making follow on biologics (FOBs) available in the US. Shapiro, Robert J. Report Mar 1, 2008 4667
MorphoSys and Novartis forge strategic alliance. Brief article Jan 1, 2008 267
Agreements. Aug 1, 2006 370

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles